Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Arihiro Aihara"'
Publikováno v:
Translational Oncology, Vol 12, Iss 10, Pp 1345-1356 (2019)
Immunomodulatory drugs such as lenalidomide (LEN) have shown significant anti-tumor activity against hematologic malignancies and they may have similar actions on solid tumors as well. We studied the effect of a new analog of the immunomodulatory dru
Externí odkaz:
https://doaj.org/article/7796b6228f154470be3400eac1493ae4
Autor:
Chiung-Kuei Huang, Yoshifumi Iwagami, Arihiro Aihara, Waihong Chung, Suzanne de la Monte, John-Michael Thomas, Mark Olsen, Rolf Carlson, Tunan Yu, Xiaoqun Dong, Jack Wands
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150336 (2016)
Cholangiocarcinoma (CCA) has a poor prognosis due to widespread intrahepatic spread. Aspartate β-hydroxylase (ASPH) is a transmembrane protein and catalyzes the hydroxylation of aspartyl and asparaginyl residues in calcium binding epidermal growth f
Externí odkaz:
https://doaj.org/article/719d75f29f624c8c8bb27f56595db1cc
Autor:
Hiromitsu Ito, Shinji Tanaka, Yoshimitsu Akiyama, Shu Shimada, Rama Adikrisna, Satoshi Matsumura, Arihiro Aihara, Yusuke Mitsunori, Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Shigeki Arii, Shoji Yamaoka, Minoru Tanabe
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146564 (2016)
Patients with pancreatic cancer typically develop tumor invasion and metastasis in the early stage. These malignant behaviors might be originated from cancer stem cells (CSCs), but the responsible target is less known about invisible CSCs especially
Externí odkaz:
https://doaj.org/article/73fba70ba8574972bd8c88adb798a784
Autor:
Shinji Tanaka, Minoru Tanabe, Shigeki Arii, Atsushi Kudo, Takanori Ochiai, Daisuke Ban, Yusuke Mitsunori, Arihiro Aihara, Satoshi Matsumura, Keisuke Nakao, Kaoru Mogushi, Yoshimitsu Akiyama, Shu Shimada, Yoshiteru Ohata
Genes commonly upregulated in HuH7-F6 and -F12 cells compared with HuH7-F0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d49b9a98ffdc2d64da0606addf50f8f
https://doi.org/10.1158/1535-7163.22503453.v1
https://doi.org/10.1158/1535-7163.22503453.v1
Autor:
Shinji Tanaka, Minoru Tanabe, Shigeki Arii, Atsushi Kudo, Takanori Ochiai, Daisuke Ban, Yusuke Mitsunori, Arihiro Aihara, Satoshi Matsumura, Keisuke Nakao, Kaoru Mogushi, Yoshimitsu Akiyama, Shu Shimada, Yoshiteru Ohata
Clinicopathological characteristics of patients with Tβ4-high and -low HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09bec4e093b2d588399c0fc9b74ff73d
https://doi.org/10.1158/1535-7163.22503450.v1
https://doi.org/10.1158/1535-7163.22503450.v1
Autor:
Shinji Tanaka, Minoru Tanabe, Shigeki Arii, Atsushi Kudo, Takanori Ochiai, Daisuke Ban, Yusuke Mitsunori, Arihiro Aihara, Satoshi Matsumura, Keisuke Nakao, Kaoru Mogushi, Yoshimitsu Akiyama, Shu Shimada, Yoshiteru Ohata
Primers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a906e02946c26c274b4bee4ced070432
https://doi.org/10.1158/1535-7163.22503456.v1
https://doi.org/10.1158/1535-7163.22503456.v1
Publikováno v:
Translational Oncology, Vol 12, Iss 10, Pp 1345-1356 (2019)
Translational Oncology
Translational Oncology
Immunomodulatory drugs such as lenalidomide (LEN) have shown significant anti-tumor activity against hematologic malignancies and they may have similar actions on solid tumors as well. We studied the effect of a new analog of the immunomodulatory dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7893f540e0f76617e2b46ce6442ca196
https://doi.org/10.1016/j.tranon.2019.07.002
https://doi.org/10.1016/j.tranon.2019.07.002
Autor:
Shinji Tanaka, Hiromitsu Ito, Satoshi Matsumura, Arihiro Aihara, Atsushi Kudo, Yusuke Mitsunori, Takanori Ochiai, Minoru Tanabe, Atsushi Oba, Susumu Kirimura, Daisuke Ban
Publikováno v:
International Surgery. 103:116-120
Recently, several studies have revealed the usefulness of biomarkers to predict the response to chemotherapy for pancreatic ductal adenocarcinoma (PDAC). Among them, human antigen R (HuR) is reported as a powerful marker for response to gemcitabine c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dadc05ffc1b25185deb8aee06a36a8f
https://doi.org/10.9738/intsurg-d-15-00278.1
https://doi.org/10.9738/intsurg-d-15-00278.1
Autor:
Satoshi Matsumura, Daisuke Ban, Atsushi Kudo, Minoru Tanabe, Arihiro Aihara, Shinji Tanaka, Takanori Ochiai, Takaki Furuyama, Yusuke Mitsunori
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 23:763-770
Background The most reliable index to predict the safety of hepatectomy for patients with poor liver function remains unknown. We aimed to construct a novel preoperative index to predict early liver failure (ELF) and mortality due to recurrence-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::912d7dc258fe5ce9fa41deab08a8e73f
https://doi.org/10.1002/jhbp.400
https://doi.org/10.1002/jhbp.400
Autor:
Hironori Koga, Miran Kim, Jing Zou, Jack R. Wands, Rolf I. Carlson, Chiung-Kuei Huang, Arihiro Aihara, Tunan Yu, Yoshifumi Iwagami, Sarah Casulli
Publikováno v:
Cancer Letters. 380:153-162
Background and aims The role of transforming growth factor beta 1 (TGFβ1) in cholangiocarcinoma (CCA) initiation and growth requires further definition. Methods We employed pharmacological and genetic approaches to inhibit or enhance TGFβ1 signalin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8de745581846a473c5d16a6217a2a8
https://doi.org/10.1016/j.canlet.2016.05.038
https://doi.org/10.1016/j.canlet.2016.05.038